ArticleInternational journal of cancer2026

Clinical implications of PD-L1 expression in oncogene-driven NSCLC: Differential responses to targeted agents and immune checkpoint inhibitors.

Xiaoxiao Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.